SynthesisChild's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery2025
Fetal myelomeningocele repair after the MOMS trial: a systematic review of neurosurgical outcomes and evolving techniques.
Synthesis in Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Case Report: Surgical management of a meningomyelocele in a cat.Frontiers in veterinary science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo review current evidence on neurosurgical and obstetric outcomes following prenatal versus postnatal repair of myelomeningocele (MMC) after the landmark Management of Myelomeningocele Study (MOMS) trial, emphasizing evolving surgical techniques and long-term implications.
methodsA systematic review was performed according to PRISMA guidelines. PubMed/MEDLINE was searched from 2011 (MOMS publication) to the present for studies on fetal MMC repair. Eligible studies included randomized trials, cohort comparisons, technical series, and evidence-based guidelines. Primary outcomes were cerebrospinal fluid (CSF) shunt placement, reversal of hindbrain herniation, and motor/ambulation function; secondary outcomes included maternal morbidity, urological, and orthopedic endpoints.
resultsForty-three studies met the inclusion criteria. Prenatal repair reduced ventriculoperitoneal shunt requirements by approximately 50% (about 40% vs. 80%) and doubled the rate of independent walking (about 45% vs. 24%) compared with postnatal repair, consistent with MOMS findings. Hindbrain herniation reversal occurred in up to 75% of prenatal cases. However, prenatal surgery increased risks of preterm delivery (around 34 weeks), premature membrane rupture, and uterine dehiscence. Refinements such as mini-hysterotomy and fetoscopy achieved similar fetal benefits with improved maternal safety profiles, depending on surgical expertise and institutional experience.
conclusionPrenatal MMC repair is one of the most significant advances in fetal neurosurgery, providing durable neurological and functional benefits such as reduced reliance on ventriculoperitoneal shunts and improved motor functions. Continued improvements in surgical techniques, maternal-obstetric safety, and equitable access to experienced fetal centers are essential to establishing prenatal surgical repair as a key advancement in modern pediatric neurosurgery and fetal therapy.
Indexed as
Identifiers
41342964What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.